Search

everythinglearnresearchcommunity

for

Search:↓

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Certain gene variations increase the risk of alopecia areata in Koreans.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Deep skin fibroblasts help recruit immune cells for better wound healing.

Placenta-derived stem cells can help study and treat spontaneous abortion.

AIDS may cause changes in the scalp that increase infection risk and hair loss.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

Avicennia marina shows potential to treat Hepatitis C by targeting key proteins.

PCOS is linked to low-grade chronic inflammation.

CD4+ skin cells may be precursors to basal cell carcinoma.

Technology enhances human design thinking, creating new possibilities.

Technology expands design thinking possibilities, requiring a hybrid, reflective approach.

Early detection, prevention, and proper management can reduce TB-IRIS complications and deaths in HIV patients.

Scalp psoriasis inflammation is mainly caused by bacteria-related triggers.

New drug uses show promise but need more research.

Alopecia areata might help slow down certain cancers.

AP-2α and AP-2β proteins are essential for healthy adult skin and hair.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Borneol Essential Oil could be a natural and safe acne treatment.

The decision tree can predict drug absorption issues with good accuracy but needs more validation and adjustments for other factors.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

Obesity is linked to many gastrointestinal diseases and needs more research for treatment development.

RXRα is crucial for proper immune response and links diet to immune function.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

The protein CCN2 controls hair growth by affecting hair follicle formation and stem cell activity in mice.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Ritlecitinib effectively treats severe Alopecia Areata by reducing harmful immune activity in the skin.